Patents by Inventor Bruno Dreckmann-Behrendt

Bruno Dreckmann-Behrendt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6166045
    Abstract: A new modification of torasemide, named modification III, has been discovered. Modification III is storage stable and achieves high levels in serum shortly after oral administration. Torasemide of modification III can be used to produce a diuretic effect. A method of making torasemide of modification III is disclosed.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: December 26, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Bruno Dreckmann-Behrendt, Artur Burger, Judith M. Rollinger
  • Patent number: 5914336
    Abstract: A method of controlling the serum solubility of orally administered torasemide is disclosed. A new crystallin modification of torasemide, called modification III which has significantly higher rates of solubilization than the known crystallin form of torasemide, modification I, is blended with amounts of modification I to produce a preselected level of torasemide in serum at a given time following administration. Compositions containing amounts of modification I and modification III, sufficient to achieve the desired serum levels of torasemide, are also disclosed.
    Type: Grant
    Filed: June 2, 1998
    Date of Patent: June 22, 1999
    Assignee: Boehringer Mannheim GmbH
    Inventor: Bruno Dreckmann-Behrendt